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ABSTRACT 
 
Expression of Virulence-Associated Protein A (VapA) of Rhodoccocus equi by Infected 
Macrophages. (April 2011) 
 
Kaytee Beth Weaver 
Department of Animal Science 
Texas A&M University 
 
Research Advisor: Dr. Noah Cohen 
Department of Large Animal Clinical Sciences 
 
Rhodococcus equi is a Gram-positive bacterium known to cause disease because of its 
ability to survive and replicate inside macrophages. Macrophages also act as antigen-
presenting cells: peptides from bacteria that have been engulfed and processed by 
macrophages are presented on the external surface of the macrophages to immune cells, 
primarily lymphocytes. Virulent R. equi contain an 85-kb plasmid that encodes for a 
virulence-associated protein A (VapA) that has been shown to be required for clinical 
disease in foals. It is unknown whether macrophages infected with virulent R. equi 
express VapA peptides on their surface. Thus, the objective of this experiment was to 
infect J774.A1 murine macrophages with virulent and avirulent strains of R. equi and to 
determine whether VapA was expressed on the surface of the infected macrophages. The 
macrophages were first infected with a virulent strain of R. equi that were labeled with a 
fluorochrome (pHrodo™; Invitrogen. Carlsbad, CA, USA), and tested using flow 
cytometry to verify that phagocytosis of R. equi by the macrophages occurred efficiently. 
After confirming that phagocytosis occurred efficiently and consistently, macrophages 
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were co-cultured with the isogenic virulent and avirulent R. equi. Macrophages infected 
with virulent but not avirulent strains of R.equi expressed VapA on their surface. 
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Rhodococcus equi is a Gram-positive bacterium found ubiquitously in the environment, 
and is the leading cause of severe pneumonia in young foals (6). Virulent strains of R. 
equi are characterized by possession of an 85-kb plasmid which encodes the virulence-
associated protein (VapA). VapA is expressed on the surface of virulent isolates of R. 
equi, and it is considered to be an immunodominant protein (2).  Rhodococcus equi is a 
facultative intracellular pathogen that is capable of replicating and surviving within 
macrophages (3). Although a substantial amount of research has focused on the 
interactions between R. equi and macrophages, there is a paucity of information 
regarding processing and presentation of VapA peptides by infected macrophages. 
Peptide antigens are expressed on the surface of antigen-presenting cells (APCs, e.g., 
macrophages) through major histocompatabilty complex (MHC) class I or II molecules. 
MHC class I molecules present endogenously-derived peptides (e.g., intracellular 
bacterial pathogens) to cluster of differentiation (CD)-8-positive cytotoxic T 
lymphocytes (CTL’s), while MHC class II molecules present exogenously derived 
peptides (e.g., extracellular bacterial pathogens) to CD-4-positive (CD-4+) T helper (Th) 
1 or Th2 lymphocytes (5). It has been demonstrated that CD-4+ Th cells and CD-8+ 
CTL’s play an important role in the clearance of R. equi. CD-8+ T lymphocytes and CD-
4+ Th cells contribute not only in secreting interferon gamma (IFN-γ), but CD-8+ CTL’s 
This thesis follows the style of Infection and Immunity.  
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recognize and lyse infected host cells (6). 
 
 
Macrophages function in the immune response by phagocytosing pathogens and 
subsequently killing them. Rhodococcus equi has been proved threatening in its ability to 
replicate within macrophages after being engulfed. (3). Rhodococcus equi can be 
ingested by macrophages following binding of R. equi to the Mac-1 receptor (a.k.a. 
complement receptor 3 [CR3]) when not opsonized by antibodies, and through the Fcγ 
RIII receptor when the bacteria are opsonized by antibodies (4). It appears that R. equi 
taken into macrophages by the Mac-1 receptor can survive intracellularly, by preventing 
phagosome-lysosome fusion and inhibiting acidification of the phagolysosome (4, 10). 
Because the fate of virulent R. equi taken up by macrophages may vary, it is unclear to 
what extent there is processing of bacterial peptides for expression on the cell surface of 
macrophages.  To our knowledge, it remains unknown whether macrophages infected 
with virulent R. equi have evidence of VapA peptides presented on their surface.  The 
purpose of this study was to determine whether a monoclonal antibody against VapA 
would bind to the cell surface of macrophages infected with virulent R. equi but not to 
macrophages infected with avirulent R. equi.  These data would provide evidence of 
antigen presentation by infected macrophages, an important step in cell-mediated 
immune recognition.  





R. equi ATCC 33701+ (a virulent strain producing VapA that was originally isolated 
from an infected foal) and ATCC 33701- (an isogenic strain lacking the virulence-
associated plasmid which encodes VapA), were streaked on brain heart infusion (BHI)  
agar plates and incubated for 48 h at 37°C. Isolated colonies were collected and shaken 
in BHI broth for 24 h at 37°C. The bacteria were washed 3 times with phosphate 
buffered saline (PBS) and diluted to an optical density of 1. For 1 trial, the bacteria were 
opsonized with 10% diluted equine serum (50% in PBS) for 30 min at 37°C with 
constant rotation before infection. 
 
Macrophage cell culture 
J774.A1 macrophages were obtained from the laboratory of Dr. Thomas Ficht, 
Department of Veterinary Pathobiology, College of Veterinary Medicine and 
Biomedical Sciences, Texas A&M University. The macrophages were cultured in 1-X 
Dulbecco’s modified Eagle medium, DMEM (Gibco-BRL, Grand Island, NY, USA), 
with 10% fetal bovine serum, FBS (Gibco), and 1% non-essential amino acids , NEAA 
(Gibco), at 37°C with 5% CO2.  In preparation for infection followed by 24 h gentamicin 
incubation to remove extracellular bacteria, 7.5 x10
5
 cells/well were placed in 6-well 
plates. The plates were incubated for 24 h to allow for the macrophages to adhere.  
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Bacterial phagocytosis by macrophages using flow cytometry 
To ensure the macrophages were taking up the R. equi, pHrodo™ phagocytosis labeling 
particles (Invitrogen) were used to label virulent R. equi (5mg/ml).  The labeled R. equi 
were opsonized with 10% of diluted serum in PBS as previously mentioned and 
introduced to the macrophages (multiplicity of infection of 30:1 bacteria: macrophage) 
for 30 min at 37°C with constant rotation. Macrophages infected with labeled R. equi 
incubated at 4°C served as negative controls along with non-infected cells incubated at 
4°C and 37°C. After incubation, all the cells were placed on ice for 5 min to stop 
phagocytosis. The tubes were centrifuged at 350 × g for 5 min, supernatants removed 
and resuspended in PBS for analysis by flow cytometry. 
 
Bacterial infection of macrophages 
Plated macrophages were infected with strains 33701+ and 33701- at a multiplicity of 
infection of 5:1 bacteria: macrophage. After incubating the cells for 30 min at 37°C with 
5% CO2 macrophages monolayers were washed twice with PBS to remove extracellular 
bacteria. Fresh DMEM with 10% FBS and 1% NEAA were added with  gentamicin 
sulfate (at a concentration of 8µg/ml of media) to the monolayers and incubated for 30 
min to kill any remaining extracellular bacteria. Macrophages then were washed twice 
with fresh DMEM media and incubated for 24 h at 37°C with 5% CO2. 
 
 Detection of VapA by flow cytometry  
The J774 cells were counted and plated at 1 x10
6 
cells/well in a 96-well v-bottom plate. 
After centrifuging (300 × g at 4°C for 3 min), the supernatant was removed and the 
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pellet was resuspended in 60 µl of blocking solution (10% normal goat serum in PBS) 
and incubated at 4°C for 20 min. Then 50 µl of monoclonal antibody against VapA 
(generously provided by Dr. Shinji Takai, Kitasato University, Japan) were added to 
each of the wells and incubated for 45 min at 4°C. The plate was then washed 3 times 
with PBS, incubated for an additional 45 min at 4°C with fluorescein isothiocyanate 
(FITC)-conjugated goat anti-mouse immunoglobulin G (IgG; Jackson ImmunoResearch, 
West Grove, PA, USA). The cells were washed 3 times with PBS and resuspended in 
FIX buffer (14% formaldehyde in PBS), transferred to a 4ml flow cytometry tube and 
analyzed on a FACScan BD biosciences flow cytometer (BD biosciences, San Jose, CA, 
USA). Negative controls included macrophages not infected with bacteria in addition to 
infected macrophages exposed to secondary antibody without primary VapA antibody. 
 
 




Infection of labeled R. equi for phagocytosis determination 
To determine whether R .equi was phagocytosed by the macrophages, pHrodo™-labeled 
R. equi particles were added in the culture after opsonization and tested on a FACScan 
flow cytometer. There was significant shift in fluorescence on the histograms of the 
negative control cells without bacteria and the infected cells (Fig. 1). It was estimated 
that approximately 30% of macrophages had evidence of intracellular R. equi (i.e, 
phagocytosis). This result affirmed that our technique of infection resulted in 




              
 
 
FIG. 1. Infection of murine macrophages with pHrodo™ R. equi labeled particles. (A) Dot blot presenting 
fluorescence of macrophages without labeled R. equi .(B) Histograms showing the intracellular fluorescence of 
phagocytosed R. equi (right) compared to negative control macrophages without bacterial infection of R. equi (left). 
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VapA expression by R. equi infected macrophages 
Macrophages infected with a virulent strain (33701+) of R. equi bound monoclonal 
antibody against VapA whereas macrophages infected with an isogenic avirulent strain 
of R. equi (33701-) did not, indicating that macrophages infected with virulent R. equi 
have VapA antigens on their surface (Fig. 2). The experiment between non-opsonized 
virulent R. equi infected macrophages and non-opsonized avirulent R. equi infected 
macrophages were replicated and results were averaged (Table 1); the experiment 
comparing macrophages infected with either opsonized or non-opsonized R. equi (both 
virulent and avirulent) was conducted only once (Table 1). Using flow cytometery, the 
average percentage of macrophages that demonstrated binding of the VapA monoclonal 
antibody to the cell surface was 6.2% for macrophages infected with non-opsonized 
virulent R. equi and 0% for macrophages infected with non-opsonized avirulent R. equi.  
For macrophages infected with opsonized R. equi, the percentage of cells with positive 
results for binding of the VapA monoclonal was 4.5% for the virulent isolate and 0% for 




TABLE 1. Expression of VapA by R. equi infected murine macrophages 
Percent Positive for VapA expression:                                                            
Strain                                         Opsonized                      Non-opsonized      
                                                                    Trial 1                  Trial 2 
 
 
33701+ 4.46 2.74 9.56 
33701-  0 0 0 
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FIG. 2. Expression of VapA by macrophages infected with avirulent (33701-) and virulent (33701+) strains of R. equi. 
(A) Flow cytometry overlay histogram of expression of VapA on macrophage surface infected with opsonized 
avirulent R. equi infected macrophage incubated with secondary FITC conjugated goat anti-mouse IgG antibody (O-
AV.NEG), and cells with both primary VapA and secondary antibody incubation (O-AV.PSA). (B) Overlay histogram 
of opsonized virulent R. equi infected macrophages incubated with only secondary FITC antibody (O-V.NEG) and 
infected cells incubated with both primary VapA and secondary antibody (O-V.PSA). (C) Overlay histogram of non-
opsonized virulent R. equi infected macrophages incubated with only secondary FITC antibody (NO-V.NEG) and 

























































Many experiments have explored the importance of the vapA plasmid in the survival and 
replication of R. equi in macrophages, and also the identification of either the VapA 
protein or the vapA gene as a diagnostic test for early R. equi detection in foals (7, 8, 11).  
It has not been reported, however, whether VapA peptides can be detected on the surface 
of macrophages infected with R. equi. In this study, we found evidence that 
macrophages infected with an isolate of R. equi bearing the plasmid encoding the vapA 
gene (i.e., a virulent isolate of R. equi), whereas macrophages infected with an isogenic 
strain of the R. equi lacking the virulence plasmid (i.e., R. equi which did not express 
VapA) did not have evidence of VapA antigens on their surface. Knowing that 
macrophages process and present VapA on their surface when infected with virulent R. 
equi is important for understanding their role in immunity towards R. equi.  Our findings 
indicate that macrophages may play a role in antigen presentation to other cells of the 
immune system following infection with virulent R. equi.  VapA is known to be highly 
immunogenic, and evidence exists that antibodies against VapA can modulate the 
outcome of infection with virulent R. equi in mice and foals (1).  Thus, infected 
macrophages might be recognized and destroyed either by antibody-dependent 
mechanisms or possibly by CTLs. Moreover, it may be important that inactivated or live 
strains of R. equi being evaluated as candidate vaccines can be documented to present 
VapA on the surface of macrophages or other APCs by which they are recognized.   
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The percentage of macrophages demonstrating phagocytosis of R. equi observed in this 
report is consistent with but somewhat less than previously reported.  Hondalus and 
Mosser (3) observed 50% of macrophages to have phagocytosed R.equi, whereas this 
experiment observed 30% phagocytosis by macrophages. The reason for the discrepancy 
between studies is unknown, but may relate to differences in study methods.  In the 
study reported here, phagocytosis was measured in a different murine macrophage cell 
line (J774.A1) and with a different strain of R. equi (33701+) than those used by 
Hondalus and Mosser. The previous experiment also did not use pHrodo™-labeled R. 
equi particles to flag the presence of intracellular R. equi.  Collectively, these differences 
could explain the variation in the percentage of phagocytosis by macrophages reported 
between studies.    
 
There was no apparent difference in the values observed between macrophages infected 
with opsonized and non-opsonized R. equi; this suggests that the method by which the 
bacteria are taken up by the macrophage may not determine the extent to which the 
macrophages present VapA on their surface. The percentage of positive macrophages 
expressing VapA on their surface was approximately 6%, irrespective of whether the 
bacteria were opsonized. Although this percentage might initially seem low, it is not 
entirely surprising for 2 reasons.  First, only 30% of infected macrophages phagocytose 
R. equi, such that approximately 21% of macrophages that engulfed R. equi had 
detectable VapA on their surface. Second, we may have underestimated the proportion 
of macrophages with VapA peptides on their surface.  This is because the monoclonal 
antibody used in this experiment is directed against the VapA protein, but only peptides 
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are expressed on the surface of macrophages.  Peptides are small and linear portions of 
proteins, many monoclonal antibodies recognize conformational epitopes of proteins. 
Therefore, our monoclonal antibody might not have bound efficiently or effectively to 
macrophages with linear peptides that represented only a portion of the VapA epitope(s) 
it recognizes or because of loss of secondary or tertiary epitope conformation (9).  
A limitation of this study is that foals are the species affected by R. equi pneumonia, but 
a murine macrophage cell line was used in this study.  Murine cells were used because 
they have been used previously and demonstrated to behave similarly to equine 
macrophages infected with R. equi (3, 4), and because there is not an equine macrophage 
cell line available.  Repeating the experiments reported here using equine macrophages 
derived from culture of alveolar macrophages obtained by bronchoalveolar lavage would 
be valuable.  Because adult horses appear to be immune to infection with R. equi, 
whereas (some) foals appear to be susceptible, it would be especially interesting to 
compare the percentage of macrophages presenting VapA on their surface following 
infection between macrophages obtained from foals and those obtained from mature 
horses.   
Another limitation of this study is that we did not detect whether the VapA was 
presented by MHC proteins, and which type of MHC molecules (class I or II) was 
involved.  While one would expect that VapA peptides would be presented in an MHC 
class I context, this remains to be established by future experiments. 
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In summary, the finding that VapA expression is found on the surface of macrophages 
infected with virulent isolates of R. equi that express this protein is an important 
contribution to understanding immunity to R. equi infection.  This finding suggests new 
avenues for research, including evaluating detecting VapA on the surface of equine 
macrophages infected with virulent R. equi, comparing macrophages of adult horses to 
foals with respect to this process, and determining the MHC molecules involved in 
binding VapA.   
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